Crinetics Pharmaceuticals Inc’s recently made public that its Chief Med and Dev Officer Pizzuti Dana unloaded Company’s shares for reported $0.79 million on Oct 03 ’24. In the deal valued at $54.63 per share,14,375 shares were sold. As a result of this transaction, Pizzuti Dana now holds 28,507 shares worth roughly $1.56 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, DANA J PIZZUTI bought 14,375 shares, generating $785,322 in total proceeds.
Before that, Wilson Marc sold 25,000 shares. Crinetics Pharmaceuticals Inc shares valued at $1,277,750 were divested by the CFO at a price of $51.11 per share. As a result of the transaction, Wilson Marc now holds 111,092 shares, worth roughly $6.08 million.
Citigroup initiated its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy in a research note published on March 06, 2024; the price target was $68. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. Jefferies began covering CRNX with “Hold” recommendation on December 21, 2023.
Price Performance Review of CRNX
On Friday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock fall -8.28% to $54.72. Over the last five days, the stock has lost -9.84%. Crinetics Pharmaceuticals Inc shares have risen nearly 53.79% since the year began. Nevertheless, the stocks have risen 89.47% over the past one year. While a 52-week high of $62.53 was reached on 11/14/24, a 52-week low of $27.55 was recorded on 01/05/24. SMA at 50 days reached $54.97, while 200 days put it at $48.56.
Levels Of Support And Resistance For CRNX Stock
The 24-hour chart illustrates a support level at 52.71, which if violated will result in even more drops to 50.70. On the upside, there is a resistance level at 58.44. A further resistance level may holdings at 62.16. The Relative Strength Index (RSI) on the 14-day chart is 41.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.13%. Stochastics %K at 43.27% indicates the stock is a holding.
How much short interest is there in Crinetics Pharmaceuticals Inc?
A steep rise in short interest was recorded in Crinetics Pharmaceuticals Inc stocks on 2024-10-31, growing by 0.17 million shares to a total of 6.94 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 6.78 million shares. There was a rise of 2.41%, which implies that there is a positive sentiment for the stock.
